TB-500

€ 50.00

€ 45.00 with crypto -10%

Have a question?

Talk to our team

Payment Options

TB-500 5 mg ⁠-⁠ Hilma Biocare

The peptide comes as a powder with 5 mg stated per vial. Its exact amino acid sequence requires confirmation because the TB-500 name is used for different peptide presentations.

Manufacturer

Hilma Biocare

Peptide

TB-500

Class

Peptide

Presentation

Powder for injectable preparation

Vial content

5 mg, equivalent to 5 000 mcg

Packaging

1 vial

How It Works

The product name refers to preparations related to thymosin beta 4, including a synthetic peptide from its actin binding region. Actin regulation affects how cells move and organise during tissue repair. The supplied specifications do not identify the peptide sequence, so the exact molecular identity cannot be confirmed from this file.

Cell Migration and Tissue Repair Research

Thymosin beta 4 research has demonstrated cell migration and blood vessel related repair activity in experimental systems. This explains interest in recovery from tendon and muscle injuries. Those findings do not establish the same effect for an unspecified TB-500 preparation or demonstrate faster recovery in healthy athletes.

  • Investigating cell movement involved in repair.
  • Studying pathways linked to actin organisation.
  • Exploring tissue repair findings from thymosin related research.

Post Cycle Therapy

The peptide has no established role in androgen suppression and no established indication for steroid PCT. Limited human data and uncertain product identity prevent a complete description of its systemic endocrine effects.

Side Effects

Human safety data for marketed TB-500 preparations are inadequate to establish reliable adverse effect rates. Injection reactions, hypersensitivity and contamination are possible concerns. Research involving full length thymosin beta 4 does not establish the safety of a different fragment or an unverified preparation.